EGFR mutant-specific immunohistochemistry has high specificity and sensitivity for detecting targeted activating EGFR mutations in lung adenocarcinoma

W. A. Cooper^*, B. Yu, P. Y. Yip, C. C. Ng, T. Lum, M. Farzin, R. J. Trent, B. Mercorella, A. Clarkson, M. R. J. Kohonen-Corish, L. G. Horvath, J. G. Kench, B. McCaughan, A. J. Gill, S. A. O'Toole

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review